On August 21, the 2017 annual meeting of the Pharmaceutical Administration Committee, sponsored by the Pharmaceutical Administration Committee of the Chinese Pharmaceutical Association and sponsored by the Pharmaceutical Administration Committee of Hunan Pharmaceutical Association, supported by enterprises such as Hunan Times Sunshine Pharmaceutical Co., Ltd., and the academic seminar on "Practicing the Concept of Healthy China and Promoting the Sustainable Development of Pharmaceutical Affairs" was held in Changsha City.

  The theme of this conference is to carry out academic discussions on the theme of "practicing the concept of healthy China and promoting the sustainable development of pharmaceutical industry". Three sub-venues, the Youth Forum for the Development of Pharmaceutical Administration Discipline, the Quality Improvement of the Chinese Medicine Industry Chain and the Safe Use and Supervision of Drugs, were set up for thematic exchanges.

   After the expert review before the meeting, the paper "Study on Quality Standards of Xiaoer Fupi Granules" submitted by Time Sunshine Pharmaceutical Industry was selected as an excellent paper. Professor Yang Hongjun, the company's chief scientist, presented a report entitled "Opportunities and Challenges for the Development of Anti-infective Chinese Patent Drugs under the Background of Anti-infective Limitation" at the "Drug Safety Use and Supervision" Branch. Professor Yang Hongjun analyzed the opportunities of Chinese patent medicines in anti-infective application from the national policy background of antimicrobial drug management. Professor Yang pointed out that some of the acute inflammation caused by microorganisms can play an anti-bacterial, anti-inflammatory and antipyretic role with high safety and broad application prospects.

 

  

      Tang Chunyu, Vice General Manager of Time Sunshine Pharmaceutical Industry, was elected as a member of the new Professional Committee of Pharmaceutical Administration of Hunan Pharmaceutical Association at the meeting held the previous day. Tang Chunyu said: As a pharmaceutical enterprise of Chinese patent medicine, the Sunshine Pharmaceutical Industry of the Times has been committed to promoting the development of national medicine. At present, Chinese medicine has encountered unprecedented opportunities for development. The Sunshine Pharmaceutical Industry of the times will adhere to the brand proposition of "real materials, sunshine medicine", and spare no effort to carry forward the quintessence of the Chinese nation. At the same time, the platform of Hunan Pharmaceutical Association is used to strengthen academic exchanges and learning, and to continue to provide pharmaceutical services and publicity to patients and medical institutions.